Air travel and prevention of venous thromboembolism by medication

Evidence Summaries

Level of Evidence = D

There is insufficient evidence on the effectiveness of medication use for the prevention of travel-related venous thromboembolism. Aspirin is probably not effective and for low-molecular-weight-heparin (LMWH) there might possibly be a trend favoring limited effect.

A systematic review 1 included 25 studies (6 case-control studies, 10 cohort studies, and 9 randomized controlled trials). Clinical venous thromboembolism (VTE) meaning pulmonary embolism (PE) or deep venous thrombosis (DVT) after prolonged travel is rare (27 symptomatic VTEs per million flights diagnosed through usual clinical care, 0.05% symptomatic DVTs diagnosed through screening ultrasounds), but asymptomatic thrombi of uncertain clinical significance are more common (ranging from 0% to 12%). Multivariate logistic regression analysis showed that mean duration of air travel >8 hours and high clinical risk of VTE ( 1 of previous DVT, prothrombotic blood disorder, body weight >90 kg, limited mobility, cancer, or large varicose veins) increased risk of air-travel-related VTE.

In randomized controlled trials, graduated compression stockings prevented travel-related VTE (P < 0.05 in 4 of 6 studies). Only 1 study evaluated LMWH (enoxaparin) and found a trend favoring effective DVT prevention that did not reach statistical significance. The same study found no effect from aspirin. No studies tested warfarin or unfractionated heparin. Two studies evaluated preparations containing pycnogenol, an extract of pine bark with antioxidant and possible antithrombotic effects with 1 study reporting fewer DVTs among treated passengers.

Comment: The quality of evidence is downgraded by study quality (most studies enrolled volunteers who tend to be healthier than nonvolunteers), by inconsistency (heterogeneity in interventions and outcomes) and by imprecise results (limited study size for each comparison).

References

1. Philbrick JT, Shumate R, Siadaty MS, Becker DM. Air travel and venous thromboembolism: a systematic review. J Gen Intern Med. 2007;22(1):107-14.


Copyright © 2017 Duodecim Medical Publications Limited.
Air travel and prevention of venous thromboembolism by medication is a sample topic from the Evidence-Based Medicine Guidelines.

To view other topics, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Learn more.

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Air travel and prevention of venous thromboembolism by medication ID - 453550 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453550/all/Air_travel_and_prevention_of_venous_thromboembolism_by_medication PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -